In conclusion, our study revealed that CXCL5 promotes tumor angiogenesis by controlling FOXD1 expression and transcriptional activity through the activation of the AKT/NF-κB pathway, suggesting that CXCL5 is a significant predictor in tumorigenesis and progression. The gene discussed is FOXD1; the disease is neoplasm.